Greenwich Lifesciences Inc (GLSI)
$17.41 -8.37% Close Oct 30, 2026 Live
Greenwich Lifesciences stock today
Greenwich Lifesciences closed at $17.41 on October 30, 2026, down 8.37% on the day. Over the past year it returned +89.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $256 million.
$10.00$20.00$30.00
NovJan 2026MarMayJulSep
| Period | GLSI | S&P 500 (SPY) |
|---|---|---|
| 1 month | -3.5% | -0.9% |
| 3 months | +24.2% | +2.1% |
| Year to date | -17.1% | +11.7% |
| 1 year | +89.4% | +12.4% |
| 3 years | +110.3% | +88.5% |
| 5 years | -50.8% | +76.0% |
Key statistics
- Market value
- $256M
- 52-week range
- $7.85 to $33.56
- Next report
- Nov 12, 2026 (estimated)
About Greenwich Lifesciences
Develops and commercializes biopharmaceutical products for cancer treatment.
Sector: Health Care
More on Greenwich Lifesciences
- Returns: what $1,000 became$1,000 five years ago is $492.36 today
No forecast, no recommendation. This page describes Greenwich Lifesciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.